Venous Thrombosis: all 787 studies

Page 8 of 8. Open to participants first (123), then studies with results posted, then the rest; newest registration first within each.

• Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and PostpartumCompletedNCT00740454
• D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 MonthsCompletedNCT00720915Not applicable
• Determination of Predictive Value of Echography Doppler AbnormalitiesStatus unknownNCT00714909
• Comparative Study Between Thrombosis Prophylaxis ProtocolsCompletedNCT00713973
• Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous ThrombosisCompletedNCT00689520Phase 4
• Venous Thrombus Investigation With Contrast Enhanced Ultrasound ImagingStatus unknownNCT00677846
• Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerCompletedNCT00660205
• Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot StudyTerminatedNCT00655122Phase 4
• Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein ThrombosisStatus unknownNCT00640731Phase 4
• Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower ExtremitiesCompletedNCT00628576Phase 3
• Absence of Residual Vein Thrombosis Permits to Withdrawn Oral AnticoagulantsCompletedNCT00623987Phase 4
• Testing Strategies to Improving Warfarin AdherenceCompletedNCT00622102Not applicable
• Prevention of Venous Thrombosis After Permanent Transvenous Leads ImplantationCompletedNCT00621491Not applicable
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic AcidCompletedNCT00603317Phase 4
• Venous Thrombosis in Turner SyndromeStatus unknownNCT00594763
• Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and OutcomeStatus unknownNCT00588757Not applicable
• Birth Control Pill vs Birth Control Patch StudyCompletedNCT00554632Not applicable
• 3 Screen Electronic AlertCompletedNCT00550082
• Registry of Hospitalized Patients Treated With FondaparinuxCompletedNCT00549705
• Venous Thromboembolism Taskforce Audit ProgramCompletedNCT00535171
• Atorvastatin for the Treatment of Retinal Vein OcclusionStatus unknownNCT00517257Phase 3
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin PrescribingStatus unknownNCT00484640Not applicable
• PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava InterruptionCompletedNCT00457158Phase 4
• Epidemiology of Venous ThromboembolismCompletedNCT00456196
• Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein ThrombosisStatus unknownNCT00450645Phase 4
• Residual Vein Thrombosis Establishes the Optimal Duration of Oral AnticoagulantsCompletedNCT00438230Phase 4
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese VolunteersCompletedNCT00436787Phase 2
• Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVTTerminatedNCT00428129Phase 2
• Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic SyndromeCompletedNCT00426075Phase 3
• Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)CompletedNCT00421538Phase 3
• Fondaparinux as Monotherapy for DVT and/or Pulmonary EmbolismCompletedNCT00413504Not applicable
• Multi-Center Human Alert Trial to Prevent DVT and PECompletedNCT00409136
• Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein ThrombosisCompletedNCT00395772Phase 2
• Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic SyndromeCompletedNCT00395265
• Ultrasound Findings to Adjust the Duration of AnticoagulationCompletedNCT00380120Phase 3
• 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PECompletedNCT00365950Phase 4
• Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein ThrombosisCompletedNCT00362947Phase 3
• The ERASMUS Study: Limited vs Extended US for DVT DiagnosisCompletedNCT00353093Not applicable
• The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsCompletedNCT00351663Phase 4
• EVENT: Hydrotherapy and Deep Venous ThrombosisTerminatedNCT00348907Phase 3
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central CathetersCompletedNCT00346424Phase 3
• Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic ApproachCompletedNCT00345618Phase 3
• US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance StatusCompletedNCT00336258
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"CompletedNCT00334464Not applicable
• Single Comprehensive Ultrasound to Rule Out DVT in High-risk PatientsCompletedNCT00333697Not applicable
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded CathetersCompletedNCT00322270Phase 3
• VITRO-Trial. B Vitamins and the Secondary Prevention of Venous ThrombosisCompletedNCT00314990Not applicable
• Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate CancerCompletedNCT00312013Phase 3
• Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsCompletedNCT00311090Phase 3
• Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee SurgeryCompletedNCT00306254Phase 2
• Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer PatientsCompletedNCT00285038
• D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of RecurrenceCompletedNCT00266045
• Enoxaparin in Acute Venous Thromboembolic DiseaseCompletedNCT00265993Phase 4
• D-dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNCT00264277Phase 4
• Understanding Risk Factors Involved in Developing a Second Blood Clot.Status unknownNCT00261014
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT StudyCompletedNCT00252005Phase 2
• Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein ThrombosisCompletedNCT00251771Not applicable
• Cystic Fibrosis and Totally Implantable Vascular Access DevicesCompletedNCT00244270Phase 4
• The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.TerminatedNCT00232271Phase 4
• The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean SectionCompletedNCT00225108Phase 2/3
• Aspirin for the Prevention of Recurrent Venous ThromboembolismStatus unknownNCT00222677Phase 2/3
• The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein ThrombosisCompletedNCT00216866Phase 2
• A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)CompletedNCT00211146Phase 3
• Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by WarfarinCompletedNCT00203658Phase 4
• Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)CompletedNCT00203580Phase 4
• The D-KAF (Dalteparin in Knee-to-Ankle Fracture) TrialCompletedNCT00187408Phase 4
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney FailureTerminatedNCT00186745Not applicable
• Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.CompletedNCT00185952Not applicable
• Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)TerminatedNCT00182546Phase 3
• Fixed Dose Heparin StudyCompletedNCT00182403Phase 3
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)CompletedNCT00182364Phase 3
• D-Dimer Vs Serial Compression Ultrasound StudyCompletedNCT00182351Phase 3
• D-Dimer and IPG for Recurrent Thrombosis (DIRECT)TerminatedNCT00182247Phase 3
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)CompletedNCT00182143Phase 3
• Sonography Outcomes Assessment Program for Lower Extremity Deep Venous ThrombosisCompletedNCT00178789
• The Use of Low Molecular Weight Heparin in Traumatic Brain InjuryCompletedNCT00170378Phase 4
• Genetic Determinants of Warfarin Anticoagulation EffectStatus unknownNCT00162435Not applicable
• Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)CompletedNCT00157677Phase 3
• MDA D-Dimer / Recurrent DVT StudyCompletedNCT00157599Not applicable
• Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the FootCompletedNCT00114608Phase 1
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00097357Phase 2/3
• SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCompletedNCT00071279Phase 3
• Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)CompletedNCT00067093Phase 3
• Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer PatientsTerminatedNCT00041782Phase 2
• Risk Factors for Venous ThromboembolismCompletedNCT00018772
• Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in ThrombosisCompletedNCT00005684
• Epidemiology of Venous Thrombosis and Pulmonary EmbolismActive, not recruitingNCT00005504

← Venous Thrombosis overview